Home › Acute Kidney Injury › Michigan
Acute Kidney Injury clinical trials in Michigan
10 studies for Acute Kidney Injury are looking for participants at sites in Michigan.
Cities in Michigan
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
- University of Michigan Hospital, Ann Arbor
Recruiting
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07224243Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
- University of Michigan, Ann Arbor
- Henry Ford Medical Center, Detroit
Recruiting
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT05758077A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
- Research Site, Detroit
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 2, 2026 · NCT07215702Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Detroit Medical Center, Detroit
- Henry Ford Health System, Detroit
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Aug 14, 2026 · NCT06699849Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney Injury
- University of Michigan, Ann Arbor
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT07016074Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
- University of Michigan, Ann Arbor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT05399537The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
- University of Michigan, Ann Arbor
- Henry Ford Health, Detroit
RecruitingPhase 4
Ages 18 and older · All sexes · Updated May 26, 2026 · NCT06802224QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry
- CS Mott Children's Hospital, Ann Arbor
RecruitingObservational study
Up to age 22 · All sexes · Updated May 14, 2026 · NCT06517810Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
- University of Michigan, Ann Arbor
Recruiting
Ages 22 to 85 · All sexes · Updated Mar 19, 2026 · NCT07017933Nafamostat Efficacy in Phase 3 Registrational CRRT Study
- Henry Ford Health, Detroit
Recruiting
Ages 18 to 80 · All sexes · Updated Oct 15, 2025 · NCT06150742From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.